Skip to content
Disclosery

MARSHALL WACE, LLP: CNS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on CNS, newest first. How the timeline and the estimate are built.

MARSHALL WACE, LLP held 19,577 CNS shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 19,577 shares
    Change vs previous 13F +2,619 shares

    <0.01% of the 13F portfolio, value $1,490,592.

    13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 16,958 shares
    Change vs previous 13F -236,809 shares

    <0.01% of the 13F portfolio, value $1,060,723.

    13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 253,767 shares
    Change vs previous 13F +69,244 shares

    0.02% of the 13F portfolio, value $15,931,494.

    13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 184,523 shares
    Change vs previous 13F -98,277 shares

    0.01% of the 13F portfolio, value $12,106,554.

    13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 282,800 shares
    Change vs previous 13F -32,875 shares

    0.03% of the 13F portfolio, value $21,308,981.

    13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 315,675 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $25,332,924.

    13F-HR 0001318757-25-000023 filed by MARSHALL WACE, LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).